SCHEMBL4685087

SCHEMBL4685087

COc1c(Cl)cccc1CC(N)=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
KMT2A Q03164 4/20 0.42
KDM4E B2RXH2 2/20 0.42
HSD17B10 Q99714 2/20 0.42
FABP4 P15090 1/20 0.41
FABP5 Q01469 1/20 0.41
MEN1 O00255 2/20 0.40
PKM P14618 1/20 0.40
RORC P51449 1/20 0.39
MRGPRX4 Q96LA9 1/20 0.39
GAA P10253 1/20 0.39
LMNA P02545 1/20 0.39
CYP3A4 P08684 1/20 0.39
HTR1A P08908 1/20 0.39
ADRA2A P08913 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
ADRA2B P18089 1/20 0.39
ADRA2C P18825 1/20 0.39
MAOA P21397 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27403679 0.88 ALDH1A1 (0.43) ALDH1A1KMT2AKDM4EHSD17B10FABP4
SCHEMBL10864328 0.85 ALDH1A1 (0.43) ALDH1A1KMT2AKDM4EHSD17B10FABP4
SCHEMBL836780 0.85 FABP4 (0.56) ALDH1A1KMT2AKDM4EHSD17B10FABP4
SCHEMBL4685083 0.83 ALDH1A1 (0.42) ALDH1A1KMT2AKDM4EHSD17B10FABP4
SCHEMBL1032325 0.81 CA12 (0.50) ALDH1A1KMT2AMEN1PKMLMNA
SCHEMBL29639810 0.80 ALDH1A1 (0.41) ALDH1A1KMT2APKMMAPK1HIF1A
SCHEMBL31075841 0.80 NLRP3 (0.47) ALDH1A1KMT2APKMLMNACYP2C9
SCHEMBL10978584 0.78 GABRA1 (0.41) ALDH1A1KMT2AKDM4EHSD17B10MEN1
SCHEMBL3393837 0.78 PNMT (0.59) ALDH1A1KMT2AKDM4EHSD17B10MEN1
SCHEMBL29760897 0.78 PNMT (0.59) ALDH1A1KMT2AKDM4EHSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101374804-A Substituted diphenylethers, -amines, -sulfides and -methanes for the treatment of respiratory disease ASTRAZENECA AB (SE) 2009-02-25 CN disclosed
EP-1902717-A2 Vasopressin antagonist and oxytocin antagonist Otsuka Pharmaceutical Company, Limited (JP) 2008-03-26 EP disclosed
EP-0620003-B1 VASOPRESSIN ANTAGONIST AND OXYTOCIN ANTAGONIST OTSUKA PHARMA CO LTD (JP) 2008-01-16 EP disclosed
US-5753644-A Vasopressin antagonist and oxytocin antagonist OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1998-05-19 US disclosed
US-5622947-A VASODILATORS, HYPOTENSIVE AGENTS, DIURETICS, PLATELET AGGLUTINATION INHIBITORS; ALSO USED TO PREVENT PREMATURE BIRTH, TREAT DYSMENORRHEA OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1997-04-22 US disclosed
EP-0514667-B1 Benzazepin derivatives as vasopressin antagonists OTSUKA PHARMA CO LTD (JP) 1995-08-09 EP disclosed
EP-0620003-A1 VASOPRESSIN ANTAGONIST AND OXYTOCIN ANTAGONIST OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1994-10-19 EP disclosed
US-5244898-A Vasopressin antagonist OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1993-09-14 US disclosed
EP-0514667-A1 Benzazepin derivatives as vasopressin antagonists OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-11-25 EP disclosed